Table 2.
Comparison of biochemical and cardiometabolic parameters between healthy control subjects and patients with MetS
| Variable | Control group (n = 75) | MetS group (n = 75) | P |
|---|---|---|---|
| FPG (mg/dL) | 93.00 (86–100) | 129 (118–145) | 0.001 |
| Insulin (μU/mL) | 11.7 (8.8–14.9) | 14.9 (12.9–18.6) | 0.001 |
| Adiponectin (µg/mL) | 17.36 (13.26–23.08) | 12.1 (9.13–18.23) | 0.001 |
| BHR (/min) | 72.90 ± 8.73 | 76.37 ± 11.55 | 0.039 |
| SBP (mmHg) | 119.05 ± 12.59 | 127.33 ± 13.79 | 0.001 |
| DBP (mmHg) | 77.29 ± 11.06 | 80.93 ± 7.23 | 0.018 |
| MAP (mmHg) | 91.21 ± 10.81 | 96.39 ± 8.56 | 0.001 |
| TC (mg/dL) | 174.87 ± 22.53 | 187.17 ± 28.89 | 0.004 |
| TG (mg/dL) | 129 (100–147) | 154 (116–180) | 0.001 |
| HDL-C (mg/dL) | 46.05 ± 4.95 | 37.73 ± 6.28 | 0.001 |
| LDL-C (mg/dL) | 105.20 ± 22.78 | 109.81 ± 27.18 | 0.350 |
| VLDL-C (mg/dL) | 24 (16–30) | 27 (19–37) | 0.050 |
| LDL-C/HDL-C | 2.34 ± 0.60 | 2.83 ± 0.91 | 0.001 |
| TG/HDL | 2.78 (2.18–3.17) | 4.17 (3.14–5.08) | 0.001 |
| TC/HDL | 3.82 ± 0.54 | 4.99 ± 1.15 | 0.001 |
| Non-HDL-C/HDL-C | 2.82 ± 0.54 | 3.99 ± 1.15 | 0.001 |
| AIP | 0.431 ± 0.12 | 0.602 ± 0.16 | 0.001 |
Values are presented as median (interquartile range) or mean ± standard deviation. FPG, insulin, BHR, SBP, DBP, MAP, and all the lipid parameters except HDL-C should be lower to be healthy; HDL-C and adiponectin should be higher.
MetS, metabolic syndrome; FPG, fasting plasma glucose; BHR, basal heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very-low-density lipoprotein cholesterol; AIP, atherogenic index of plasma.